| HOME >> MEDICINE >> TECHNOLOGY |
Solta Medical, Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands of dollars, except share and per share data)(unaudited)Three Months EndedTwelve Months EndedDecember 31,December 31,2012201120122011Net revenue
$39,801$33,168$144,545$115,984Cost of revenue
15,63014,06455,36842,364Gross margin
24,17119,10489,17773,620Operating expenses:Sales and marketing
13,64312,24453,66546,761Research and development
5,3825,24620,54916,124General and administrative
4,8055,44018,63717,443Remeasurement of contingent consideration liability
(500)1,20032,100322Total operating expenses
23,33024,130124,95180,650Income (loss) from operations
841(5,026)(35,774)(7,030)Interest income
671459Interest expense
(936)(119)(2,014)(209)Other income and expense, net
77(121)(24)(309)Loss before income taxes
(12)(5,259)(37,798)(7,489)Income tax provision (benefit)
33(6,306)210(6,160)Net income (loss)
($45)$1,047($38,008)($1,329)Net income (loss) per share:Basic
($0.00)$0.02($0.59)($0.02)Diluted
($0.00)$0.02($0.59)($0.02)Weighted average shares outstanding used in calculating net income (loss) per share:Basic
68,636,72560,959,18964,437,42760,573,428Diluted
68,636,72562,044,55564,437,42760,573,428Solta Medical, Inc.NON-GAAP RECONCILIATION OF GROSS MARGIN, OPERATING INCOME (LOSS), EBITDA, NET INCOME (LOSS) AND NET INCOME (LOSS) PER SHARE (in thousands, except share and per share data)(unaudited)Three Months EndedTwelve Months EndedDecember 31,December 31,2012201120122011GAAP Gross margin
$24,171$19,104$89,177$73,620GAAP gross margin as % of sales
61%58%62%63%Non-GAAP adjustments to gross margin:GAAP Gross margin
$24,171$19,104$89,177$73,620Amortization and other non-cash acquisi
'/>"/>
| SOURCE Solta Medical, Inc. Copyright©2012 PR Newswire. All rights reserved |